Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.06-38 Mesothelioma Stem Cells May Be the Critical Factor of Treatment Failure

Journal of Thoracic Oncology

English

MA19.09 Concurrent Mutations in STK11 and KEAP1 Is Associated With Resistance to PD-(L)1 Blockade in Patients With NSCLC Despite High TMB

Journal of Thoracic Oncology

English

P057 Pembrolizumab + Chemo vs Chemo Alone as First Line Treatment in PD-L1 Positive Advanced NSCLC: A Meta-Analysis

Journal of Thoracic Oncology

English

P2.09-02 Comprehensive Assessment of PD-L1 Immunohistochemistry on Paired Tissue and Cytology Specimens in Non-Small Cell Lung Cancer

Journal of Thoracic Oncology

English

P1.16-05 Effect of Induction Chemotherapy in the PACIFIC Study

Journal of Thoracic Oncology

English

P2.09-26 Clinical Significance of Subcellular Localization of Maspin in Patients With Pathological Stage IA Lung Adenocarcinoma

Journal of Thoracic Oncology

English

P2.17-31 the Effect of the Extended Bilateral Mediastinal Lymph Node Dissection Through a Median Sternotomy for Non-Small-Cell Carcinoma of the Left Lung.

Journal of Thoracic Oncology

English

MA20.07 Lung Cancer Screening for Limited-Resource Patients: Preliminary Findings From a Low-Dose CT Pilot Program

Journal of Thoracic Oncology

English

P1.03-33 Mutational Spectrum and Prognosis of Non-Small-Cell Lung Cancer Harboring MTOR Mutations in Chinese Population

Journal of Thoracic Oncology

English

P061 Real Clinical Practice of Using Immunotherapy in NSCLC Patients With EGFR Mutation

Journal of Thoracic Oncology

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications in Oncology

P2.06-38 Mesothelioma Stem Cells May Be the Critical Factor of Treatment Failure

MA19.09 Concurrent Mutations in STK11 and KEAP1 Is Associated With Resistance to PD-(L)1 Blockade in Patients With NSCLC Despite High TMB

P057 Pembrolizumab + Chemo vs Chemo Alone as First Line Treatment in PD-L1 Positive Advanced NSCLC: A Meta-Analysis

P2.09-02 Comprehensive Assessment of PD-L1 Immunohistochemistry on Paired Tissue and Cytology Specimens in Non-Small Cell Lung Cancer

P1.16-05 Effect of Induction Chemotherapy in the PACIFIC Study

P2.09-26 Clinical Significance of Subcellular Localization of Maspin in Patients With Pathological Stage IA Lung Adenocarcinoma

P2.17-31 the Effect of the Extended Bilateral Mediastinal Lymph Node Dissection Through a Median Sternotomy for Non-Small-Cell Carcinoma of the Left Lung.

MA20.07 Lung Cancer Screening for Limited-Resource Patients: Preliminary Findings From a Low-Dose CT Pilot Program

P1.03-33 Mutational Spectrum and Prognosis of Non-Small-Cell Lung Cancer Harboring MTOR Mutations in Chinese Population

P061 Real Clinical Practice of Using Immunotherapy in NSCLC Patients With EGFR Mutation